The childhood cerebral form of adrenoleukodystrophy (ALD) is a fatal demyelinating disease, yet mice deficient in the ALD gene do not show such clinicopathological phenotype. We have therefore investigated in human autopsy tissues whether the ALD gene mutation results in apoptosis of CNS cells. Specimens from telencephalic and brainstem regions of four patients, and three controls were examined for internucleosomal DNA fragmentation, in situ detection of DNA breaks by the TUNEL method, and caspase-3 immunostaining. None of the controls showed significant apoptosis in white matter, while apoptotic nuclei with chromatin alterations were detected in areas of active demyelination in three ALD patients. A large proportion of apoptotic cells were oligodendrocytes and some express activated caspase-3. TUNEL-positive nuclei and/or caspase-3 staining were also detected in perivascular infiltrates and, occasionally, in neurons. We conclude that apoptosis of oligodendrocytes may account, at least in part, for the demyelinating process in the ALD brain.
INTRODUCTION
X-linked adrenoleukodystrophy (ALD) is the most frequent leukodystrophy of childhood, affecting approximately 1/20,000 boys. The disease is characterized by progressive central nervous system (CNS) demyelination with an inflammatory component, adrenal insufficiency, and accumulation of very long chain fatty acids (VLCFA) in blood and brain as well as other organs (reviewed in Aubourg and Mandel, 1996; Dubois-Dalcq et al., 1999; Moser, 1997) . A variety of clinical presentations are observed within the same ALD kindred. The cerebral demyelinating form of ALD affects mainly boys between 5 and 12 years (40% of ALD cases) and leads to a vegetative state and/or death within 2-5 years. The adult form (adrenomyeloneuropathy or AMN, 40% of ALD cases) affects the spinal cord and leads to spastic paraplegia but, at later stages, cerebral demyelination often occurs (35%). Six years ago, positional cloning led to the identification of the gene mutated in ALD (Mosser et al., 1993) . It encodes an ATP-binding cassette (ABC) half-transporter of 75 kDa (ALDP) that dimerizes with itself or a related partner to exert its function within the peroxisomal membrane (Liu et al., 1999; Mosser et al., 1993) . There are three other ABC half-transporters with homology to ALDP but, so far, only ALDP is known to be associated with a CNS disease. In CNS, expression of ALDP is mostly restricted to glial cellsastrocytes, microglia and oligodendrocytes-and this pattern correlates with the demyelinating process observed in ALD patients (Fouquet et al., 1997) . VLCFA, fatty acids with chain length of 24 carbons and above, are normally activated as VLCFA-CoA derivatives by VLCFA-CoA synthetase (VLACS) before becoming
